References
  1. Elizabeth A Stewart. Uterine fibroids. The Lancet. 2001;357: 293-298
  2. D.D. Baird, D.B. Dunson, M.C. Hill, D. Cousins, J.M. Schectman. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Obstet. Gynecol. 2003;188:100–107
  3. Peitsidis P, Koukoulomati A. Tranexamic acid for the management of uterine fibroid tumors: A systematic review of the current evidence. World J Clin Cases. 2014;2:893-8
  4. Chen I, Motan T, Kiddoo D. Gonadotropin-releasing hormone agonist in laparoscopic myomectomy: systematic review and meta-analysis of randomized controlled trials. J Minim Invasive Gynecol. 2011;18:303-9
  5. Steinauer J, Pritts EA, Jackson R, et al. Systematic review of mifepristone for the treatment of uterine leiomyomata. Obstet Gynecol. 2004;103:1331-6
  6. Moroni RM, Martins WP, Ferriani RA, et al. Add-back therapy with GnRH analogues for uterine fibroids. Cochrane Database Syst Rev. 2015;20;854
  7. E. P. Barnard, A.M. AbdElmagied, S.K. Laughlin-Tommaso, et al., Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis. Am. J. Obstet. Gynecol. 2017;216:500.e1–500.e11
  8. Haar G, Coussios C. High intensity focused ultrasound: physical principles and devices.Int. J. Hyperthermia. 2007;23:89-104
  9. Coussios CC, Farny CH, Haar GT et al. Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU).Int. J. Hyperthermia. 2007;23:105-120
  10. Hynynen K, Freund WR, Cline HE et al. A clinical, non-invasive, MR imaging–monitored ultrasound surgery method. Radiographics. 1996;16:185-195
  11. Kim YS. Advances in MR image-guided high-intensity focused ultrasound therapy.Int. J. Hyperthermia. 2015;31:225-232
  12. He M,Jacobson H,Zhang C et al. A retrospective study of ultrasound-guided high intensity focussed ultrasound ablation for multiple uterine fibroids in South Africa. Int. J. Hyperthermia. 2018;5:1-7
  13. K.Funaki, H. Fukunishi, T. Funaki, K. Sawada, Y. Kaji, Maruo, Takeshi. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of pre-existing T2-weighted magnetic resonance images, Obstet. Gynecol. 2007;196:184.e1–184.e6
  14. B. Keserci, N.M. Duc, Magnetic resonance imaging parameters in predicting the treatment outcome of high-intensity focused ultrasound ablation of uterine fibroids with an immediate non-perfused volume ratio of at least 90%, Acad. Radiol. 2018;25:1257–1269
  15. R. Chen, B. Kerserci, H. Bi, et al., The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China, J. Ther. Ultrasound 2016;4:27
  16. S.L. Tung, T.Y. Chou, H.S. Tseng, C.M. Lee, A retrospective study of magnetic resonance-guided focused ultrasound ablation for uterine myoma in Taiwan, Taiwanese J. Obstet. Gynecol. 2016;55:646–649
  17. J.H. Jeong, G.P. Hong, Y.R. Kim, J.E. Ha, K.S. Lee, Clinical consideration of treatment to ablate uterine fibroids with magnetic resonance imaging-guided high intensity focused ultrasound (MRgFUS): sonalleve, J. Menopausal Med. 2016;22:94 –107
  18. Y. Xu, Z. Fu, L. Yang, Z. Huang, W.Z. Chen, Z. Wang, Feasibility, safety, and efficacy of accurate uterine fibroid ablation using magnetic resonance imaging-guided high intensity focused ultrasound with shot sonication, J. Ultrasound Med. 2015;34:2293 –2303
  19. Mindjuk, C.G. Trumm, P. Herzog, R. Stahl, M. Matzko, MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre, Eur. Radiol. 2013;25:1317 –1328
  20. N. Tan, D. Lu, S. Raman, S. Bahrami, MR guided focused US for treatment of uterine fibroids: symptom reduction in a multicenter trial using a novel treatment algorithm, J. Ther. Ultrasound 3 (Suppl. 1). 2015:91
  21. V.L. Jacoby, M.P. Kohi, L. Poder, A. Jacoby, J. Lager, M. Schembri, PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance-guided focused ultrasound for uterine fibroids, Fertil. Steril. 2016;105:773 –780
  22. M.J. Park, Y.S. Kim, H. Rhim, H.K. Lim, Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy, J. Vasc. Interv. Radiol. 2014;25:231 –239
  23. Y. Himabindu, M. Sriharibabu, V. Nyapathy, A. Mishra, Early evaluation of magnetic resonance imaging-guided focused ultrasound sonication in the treatment of uterine fibroids, Indian J. Med. Res. 2014;139:267 –272
  24. K.R.P. Gorny, B.J.P. Borah, D.L.M. Brown, D.A.M. Woodrum, E.A.M. Stewart, G.K.M. Hesley, Incidence of additional treatments in women treated with MR Guided focused US for symptomatic uterine fibroids: review of 138 patients with an average follow-up of 2.8 years, J. Vasc. Interv. Radiol.2014;25:1506 –1512
25. K.K. Funaki, H. Fukunishi, K. Sawada, Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up, Ultrasound Obstet. Gynecol. 2009;34:584 –589
26. Y. Morita, N. Ito, H. Hikida, S. Takeuchi, K. Nakamura, H. Ohashi, Non-invasive magnetic resonance imaging-guided focused ultrasound treatment for uterine fibroids - early experience, Eur. J. Obstet. Gynecol. Reprod. Biol. 2008;139:199 –203
27. A. Dobrotwir, E. Pun, Clinical 24 month experience of the first MRgFUS unit for treatment of uterine fibroids in Australia, J. Med. Imaging Radiat. Oncol. 2012;56:409 –416
28. D. Sacks, T.E. McClenny, J.F. Cardella, C.A. Lewis, Society of interventional radiology clinical practice guidelines, J. Vasc. Interv. Radiol. 2003;14:S199 –S202
29. J.B. Spies, K. Coyne, N. Guaou Gulou, D. Boyle, K. Skyrnarz-Murphy, S.M. Gonzalves, The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata, Obstet. Gynecol.2002;99:290 –300
30. J.B. Spies, L.D. Bradley, R. Guido, G.L. Maxwell, B.A. Levine, K. Coyne, Outcomes from leiomyoma therapies: comparison with normal controls, Obstet. Gynecol. 2011;117:987 –988
31. I.T. Manyonda, M. Bratby, J.S. Horst, N. Banu, M. Gorti, A. Belli, Uterine artery embolization versus myomectomy: impact on quality of life —results of the FUME (Fibroids of the uterus: myomectomy versus embolization) trial, Cardiovasc. Intervent. Radiol. 2012;35:530 –536
32. J.S. Lee, G.Y. Hong, K.H. Lee, T.E. Kim, Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid, BJOG. 2017;124:18 –22
33. V.Y. Cheung, T.P. Lam, C.R. Jenkins, G.K. Cheung, S.S. Chan, W.K. Choi, Ovarian reserve after ultrasound-guided high-intensity focused ultrasound for uterine fibroids: preliminary experience, J. Obstet. Gynaecol. Can. 2016;38:357 –361
34. H. Zowall, J.A. Cairns, C. Brewer, D.L. Lamping, W.M.W. Gedroyc, L. Regan, Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids, Obstet. Gynecol. Surv. 2008;63:427 –428
35. A.K. O ’Sullivan, D. Thompson, P. Chu, D.W. Lee, E.A. Stewart, M.C. Weinstein, Cost-effectiveness of magnetic resonance-guided focused ultrasound for the treatment of uterine fibroids, Int. J. Technol. Assess. Health Care. 2009;25:14 –25
36. C.Y. Kong, L. Meng, Z.B. Omer, et al., MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis, Am. J. Roentgenol. 2014;203:361 –371
37. A.H. Cain-Nielsen, J.P. Moriarty, E.A. Stewart, B.J. Borah, Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA, J. Comp. Eff. Res. 2014;3:503 –514
38. V. Babashov, S. Palimaka, G. Blackhouse, D. O ’Reilly, Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) for treatment of symptomatic uterine fibroids: an economic analysis, Ont. Health Technol. Assess. Ser. 2015;15:1 –61
39. O.C. Smart, J.T. Hindley, L. Regan, W.M.W. Gedroyc, Magnetic resonance-guided
focused ultrasound surgery of uterine fibroids–the tissue effects of GnRH agonist
pretreatment. Eur. J. Radiol. 2006;59(2):163–167.
40. P.F.M. Peregrino, M. de Lorenzo Messina, R. Dos Santos Simoes, J.M. Soares-Junior,
E.C. Baracat, Review of magnetic resonance-guided focused ultrasound in the
treatment of uterine fibroids, Clinics Sao Paulo (Sao Paulo) 72 (10) (2017)
637–641.
41. G. Pron, Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)
treatment of symptomatic uterine fibroids: an evidence-based analysis, Ont. Health
Technol. Assess. Ser. 2015;15:1–86.
42. S.K. Laughlin-Tommaso, A.L. Weaver, L.E. Vaughan, V. Jacoby, E.A. Stewart, Long term outcomes in a randomized controlled trial of uterine artery embolization and MR-guided focused ultrasound: the first study, Fertil. Steril. 2017;108: e26.